Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Insignia™ Hip Stem Outcomes Study - A Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Insignia™ Hip Stem for Total Hip Replacement Surgery

NCT05144191 is registered in ClinicalTrials.gov with Stryker Orthopaedics as lead sponsor.

NCT NCT05144191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05144191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Insignia™ Hip Stem Outcomes Study - A Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Insignia™ Hip Stem for Total Hip Replacement Surgery
Lead sponsor
Stryker Orthopaedics
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 7, 2022
Completion date
April 2, 2034
Enrollment
313 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, femoral neck fractures, hip osteoarthritis, post-traumatic osteoarthritis, rheumatoid arthritis, surgery, trochanteric fractures